AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Total Current Assets

All assets expected to be converted to cash or used up within one year.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Total Current Assets · Q3 FY2025 · quarter ended Sep 2025

Total current assets of €133.01M in Q3 FY2025

Q3 FY2025 total current assets was €133.01M.

Context

  • Total current assets amounted to 80.3% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€133.01M— QoQ
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Current Assets history

Currency unavailable · from the balance sheet

No Total Current Assets data reported for this period type.

Total Current Assets vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
  • Total current assets amounts to 80.3% of total assets for AGMB, versus a peer median of 93.8%.
AGMB Competitors
Total Current Assets for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALMSAlumis Inc. Common StockJun 2026$514.08M USD-0.7%+45.9%91.7%
ANABAnaptysBio, Inc.Mar 2026$316.11M USD-12.9%-7.8%95.9%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€133.01M EUR——80.3%
ACRSAclaris Therapeutics, Inc.Mar 2026$110.23M USD+1.3%-13.2%55.5%
EQEquillium, Inc.Mar 2026$62.28M USD+284.0%-26.7%98.7%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —+0.3%-10.5%93.8%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.